Alberto Albanese
#146,128
Most Influential Person Now
Italian neurologist
Alberto Albanese's AcademicInfluence.com Rankings
Alberto Albanesemedical Degrees
Medical
#2756
World Rank
#3189
Historical Rank
Neurology
#260
World Rank
#340
Historical Rank
Alberto Albanesephilosophy Degrees
Philosophy
#7873
World Rank
#11149
Historical Rank
Logic
#4906
World Rank
#6244
Historical Rank
Download Badge
Medical Philosophy
Alberto Albanese's Degrees
- Doctorate Medicine University of Milan
- PhD Neurology University of Milan
Why Is Alberto Albanese Influential?
(Suggest an Edit or Addition)Alberto Albanese's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 (2004) (3255)
- Phenomenology and classification of dystonia: A consensus update (2013) (1573)
- Consensus statement on the diagnosis of multiple system atrophy (1998) (1415)
- Rivastigmine for dementia associated with Parkinson's disease. (2004) (1113)
- Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. (2005) (1030)
- PINK1 mutations are associated with sporadic early‐onset parkinsonism (2004) (506)
- Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. (2001) (469)
- Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease (1999) (452)
- The impact of deep brain stimulation on executive function in Parkinson's disease. (2000) (441)
- Analysis of blink rate patterns in normal subjects (1997) (437)
- Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease (2010) (400)
- The natural history of multiple system atrophy: a prospective European cohort study (2013) (376)
- Levodopa in the treatment of Parkinson's disease: Current controversies (2004) (370)
- A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. (1999) (361)
- Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. (2010) (359)
- Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation (2012) (350)
- EFNS guidelines on diagnosis and treatment of primary dystonias (2011) (320)
- A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. (1998) (309)
- A prevalence study of primary dystonia in eight European countries (2000) (302)
- A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS‐ES Task Force (2006) (270)
- Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. (2003) (246)
- Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease (2002) (245)
- Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. (2008) (235)
- Diagnostic criteria for Parkinson's disease (2003) (233)
- Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. (2013) (226)
- White Matter Involvement in Idiopathic Parkinson Disease: A Diffusion Tensor Imaging Study (2009) (225)
- Clinical and subclinical dopaminergic dysfunction in PARK6‐linked parkinsonism: An 18F‐dopa PET study (2002) (212)
- Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry (2010) (212)
- Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study (2017) (208)
- Red flags for multiple system atrophy (2008) (198)
- Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson’s disease (2003) (194)
- Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians (2005) (190)
- Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY (2011) (186)
- Botulinum toxin for chronic anal fissure (1994) (167)
- Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis (2015) (166)
- Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis (2011) (164)
- Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. (1995) (161)
- Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. (2002) (159)
- Safety and efficacy of botulinum toxin type A following long‐term use (2006) (154)
- Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? (2014) (146)
- Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dosage regimens. (1998) (146)
- Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. (2002) (146)
- Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature. (1999) (143)
- Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease (2009) (142)
- Consensus statement on the diagnosis of multiple system atrophy (1998) (142)
- Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson’s disease (2006) (134)
- Efficacy of pallidal stimulation in isolated dystonia: a systematic review and meta‐analysis (2017) (133)
- Park6‐linked parkinsonism occurs in several european families (2002) (132)
- Dystonia rating scales: Critique and recommendations (2013) (131)
- Disulfide-Dependent Multimeric Assembly of Resistin Family Hormones (128)
- The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration (2005) (127)
- Organization of the ascending projections from the ventral tegmental area: A multiple fluorescent retrograde tracer study in the rat (1983) (125)
- Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. (2000) (124)
- A genome-wide association study in multiple system atrophy (2016) (122)
- Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review (2013) (118)
- Targeting the basal ganglia for deep brain stimulation in Parkinson's disease. (2000) (117)
- Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group (1998) (115)
- Aging is associated with a diffuse impairment of forebrain cholinergic neurons (1990) (111)
- Early DEtection of wEaring off in Parkinson disease: the DEEP study. (2014) (108)
- Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. (2013) (108)
- Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale (2013) (103)
- Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease (2001) (102)
- Health‐related quality of life in multiple system atrophy (2006) (101)
- Botulinum neurotoxins for post‐stroke spasticity in adults: A systematic review (2009) (101)
- DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13–36.32 in an Italian family with cranial‐cervical or upper limb onset (2001) (98)
- Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. (1998) (93)
- Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint (1999) (90)
- Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). (2011) (88)
- The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease (2005) (85)
- Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: Long‐term observation (2009) (82)
- Sex-related influences on the frequency and age of onset of primary dystonia (1999) (79)
- The European Multiple System Atrophy-Study Group (EMSA-SG) (2005) (78)
- PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum (2008) (77)
- Clinical usefulness of apomorphine in movement disorders. (1994) (76)
- Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up (2014) (73)
- Severe constipation in parkinson's disease relieved by botulinum toxin (1997) (72)
- Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome (2000) (71)
- Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. (1995) (71)
- Inclusion and exclusion criteria for DBS in dystonia (2011) (71)
- Botulinum neurotoxin to treat chronic anal fissure: results of a randomized ‘Botox vs. Dysport’ controlled trial (2004) (69)
- Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association (2012) (69)
- Treatment of Outlet Obstruction Constipation in Parkinson's Disease With Botulinum Neurotoxin A (2003) (67)
- Terminology for preparations of botulinum neurotoxins: what a difference a name makes. (2011) (66)
- Treatable inherited rare movement disorders (2018) (66)
- Phenotypic characterisation of autosomal recessive PARK6‐linked parkinsonism in three unrelated Italian families (2001) (66)
- Conflict-dependent dynamic of subthalamic nucleus oscillations during moral decisions (2011) (66)
- Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin (2017) (65)
- Levodopa-induced dyskinesias and their management (2008) (65)
- The clinical expression of primary dystonia (2003) (65)
- Fifteen-Year Experience in Treating Blepharospasm with Botox or Dysport: Same Toxin, Two Drugs (2009) (65)
- Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group (1999) (65)
- Mitochondrial dysfunction in Parkinson disease: evidence in mutant PARK2 fibroblasts (2015) (64)
- Acetylcholinesterase and catecholamine distribution in the locus ceruleus of the rat 1 1 Address for correspondence: Dr. Larry L. Butcher, Department of Psychology, University of California, 405 Hilgard Avenue Los Angeles, CA 90024. (1980) (64)
- Mutation screening of the DYT6/THAP1 gene in Italy (2009) (61)
- Synergistic Control of Protein Kinase Cγ Activity by Ionotropic and Metabotropic Glutamate Receptor Inputs in Hippocampal Neurons (2006) (60)
- Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (1988) (58)
- Organization of central nervous system dopaminergic pathways. (1986) (58)
- Suicide after successful deep brain stimulation for movement disorders (2005) (57)
- Zolpidem in Parkinson's disease (1997) (57)
- Acute Challenge with Apomorphine and Levodopa in Parkinsonism (2000) (56)
- Substantia nigra in Parkinson’s disease: a multimodal MRI comparison between early and advanced stages of the disease (2014) (55)
- GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort (2020) (55)
- The diagnostic challenge of primary dystonia: Evidence from misdiagnosis (2010) (55)
- Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement (2015) (54)
- Dystonia: diagnosis and management (2019) (54)
- Locus ceruleus somata contain both acetylcholin esterase and norepinephrine: Direct histochemical demonstration on the same tissue section (1979) (54)
- Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. (1996) (54)
- In vivo evidence for GABAA receptor changes in the sensorimotor system in primary dystonia (2011) (53)
- Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson's disease. (2012) (53)
- Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years (2015) (53)
- Abnormal tactile temporal discrimination in psychogenic dystonia (2011) (53)
- Non-DYT1 dystonia in a large Italian family. (1997) (53)
- Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease (2012) (52)
- Surgical treatment of Parkinson’s disease (1999) (52)
- A neurophysiological study of myoclonus in patients with DYT11 myoclonus‐dystonia syndrome (2008) (52)
- Relief by botulinum toxin of voiding dysfunction due to prostatitis (1998) (51)
- Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up. (2003) (51)
- Genome‐wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? (2014) (50)
- Primary torsion dystonia: the search for genes is not over (1999) (50)
- Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: Behavioural, morphological and biochemical correlates (1993) (49)
- Is this dystonia? (2009) (49)
- Disability and profiles of functioning of patients with Parkinson's disease described with ICF classification (2011) (49)
- The organization of dopaminergic and non-dopaminergic mesencephalo-cortical neurons in the rat (1982) (48)
- Pathological gambling in Parkinson's disease: Subthalamic oscillations during economics decisions (2013) (48)
- Outcome predictors, efficacy and safety of Botox and Dysport in the long‐term treatment of hemifacial spasm (2009) (45)
- Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus. (2008) (45)
- Age-dependent loss of cholinergic neurones in basal ganglia of rats (1988) (44)
- Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin (1989) (44)
- Choline acetyltransferase (ChAT) activity differs in right and left human temporal lobes. (1981) (44)
- Dystonia and Tremor: The Clinical Syndromes with Isolated Tremor (2016) (44)
- PARK6 is a common cause of familial parkinsonism (2002) (43)
- Diagnosis and management of dural arteriovenous fistulas: A 10 years single-center experience (2015) (43)
- Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: preliminary physiological results (2001) (43)
- Review article The use of botulinum toxin in the alimentary tract (1995) (42)
- Olfactory dysfunction in Parkinsonism caused by PINK1 mutations (2009) (42)
- Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia (2018) (41)
- High frequency stimulation of the subthalamic nucleus is efficacious in Parkin disease (2005) (40)
- Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial (2021) (40)
- Rosette-forming glioneuronal tumour of the fourth ventricle: report of a case with clinical and surgical implications (2004) (40)
- Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm. (1992) (38)
- Deep brain stimulation for movement disorders. Considerations on 276 consecutive patients (2011) (38)
- Minimally invasive direct coronary artery bypass improves late survival compared with drug-eluting stents in isolated proximal left anterior descending artery disease: a 10-year follow-up, single-center, propensity score analysis. (2014) (38)
- Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene (2004) (38)
- Analysis of blink rate in patients with blepharospasm (2006) (37)
- Phenotypic characterization of DYT13 primary torsion dystonia (2004) (37)
- Strain-dependent variations in the number of forebrain cholinergic neurons (1985) (37)
- The New Classification System for the Dystonias: Why Was It Needed and How Was It Developed? (2014) (37)
- Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicity (1988) (36)
- Cholinergic and non-cholinergic forebrain projections to the interpenduncular nucleus (1985) (36)
- Clinical and neuropsychological correlates in two brothers with pantothenate kinase–associated neurodegeneration (2005) (36)
- Results by motor cortex stimulation in treatment of focal dystonia, Parkinson's disease and post-ictal spasticity. The experience of the Italian Study Group of the Italian Neurosurgical Society. (2008) (36)
- Non‐DYT1 early‐onset primary torsion dystonia: Comparison with DYT1 phenotype and review of the literature (2006) (35)
- Subclinical sensory abnormalities in unaffected PINK1 heterozygotes (2008) (34)
- Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease (2015) (34)
- Progression of dysautonomia in multiple system atrophy: a prospective study of self‐perceived impairment (2007) (33)
- Spontaneous neuronal activity of the posterior hypothalamus in trigeminal autonomic cephalalgias (2007) (33)
- A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. (2003) (32)
- Surgery of Parkinson's disease: inclusion criteria and follow-up (2003) (32)
- Phenotypic variability of DYT1‐PTD: Does the clinical spectrum include psychogenic dystonia? (2002) (31)
- Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia (2003) (31)
- Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives (2002) (31)
- Dopaminergic therapy and subthalamic stimulation in Parkinson’s disease: a review of 5-year reports (2010) (30)
- Update on dystonia. (2012) (30)
- Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology (2020) (30)
- Alpha‐synuclein gene duplication: Marked intrafamilial variability in two novel pedigrees (2013) (29)
- Motor features and response to oral levodopa in patients with Parkinson’s disease under continuous dopaminergic infusion or deep brain stimulation (2012) (29)
- Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance (2019) (29)
- Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study (2020) (29)
- Obsessive-compulsive behaviour and cognitive impairment in a parkinsonian patient after left putaminal lesion. (1997) (28)
- Functioning and disability in Parkinson's disease (2010) (28)
- Epidural premotor cortical stimulation in primary focal dystonia: Clinical and 18F‐fluoro deoxyglucose positron emission tomography open study (2012) (27)
- How Many Dystonias? Clinical Evidence (2017) (26)
- Italian family with cranial cervical dystonia: Clinical and genetic study (1999) (26)
- Neurological features in SARS-CoV-2-infected patients with smell and taste disorder (2020) (26)
- Presumptive myocarditis with ST-Elevation myocardial infarction presentation in young males as a new syndrome. Clinical significance and long term follow up (2011) (26)
- STN DBS in PD (2006) (26)
- Clinical management of pain and fatigue in Parkinson's disease. (2012) (25)
- Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy. (2018) (25)
- NMDA receptor gene variations as modifiers in Huntington disease: a replication study (2011) (24)
- Differential diagnosis of dystonia (2010) (24)
- The Italian Dystonia Registry: rationale, design and preliminary findings (2017) (24)
- Anterior rectocele due to obstructed defecation relieved by botulinum toxin. (2001) (24)
- Smoking cessation before coronary artery bypass grafting improves operative outcomes. (2014) (23)
- Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms (2004) (23)
- Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease (2006) (23)
- Present status and new perspectives in laser welding of vascular tissues. (2011) (23)
- Targeting the brain: considerations in 332 consecutive patients treated by deep brain stimulation (DBS) for severe neurological diseases (2012) (23)
- Mood disorder following DBS of the left amygdaloid region in a dystonia patient with a dislodged electrode (2008) (23)
- Clozapine in Huntington's disease (1995) (22)
- Impaired body movement representation in DYT1 mutation carriers (2008) (22)
- Dystonia: clinical approach. (2007) (22)
- Quantitative gait analysis in parkin disease: Possible role of dystonia (2016) (21)
- Transient gender-related effects in Parkinson’s disease patients with subthalamic stimulation (2010) (21)
- Transcriptional profile characterization for the identification of peripheral blood biomarkers in patients with cerebral aneurysms. (2013) (21)
- Low‐Voltage Bilateral Pallidal Stimulation for Severe Meige Syndrome in a Patient With Primary Segmental Dystonia: Case Report (2010) (21)
- Isolated limb dystonia as presenting feature of Parkin disease (2014) (21)
- Therapeutic advances in dystonia (2015) (20)
- Long-term ventralis intermedius thalamic stimulation for parkinsonian tremor. Italian Registry for Neuromodulation in Movement Disorders. (1999) (20)
- Fixed dystonia unresponsive to pallidal stimulation improved by motor cortex stimulation (2007) (20)
- Genetically determined cholinergic deficiency in the forebrain of C57BL/6 mice (1994) (20)
- Angioarchitectural features of brain arteriovenous malformations associated with seizures: a single Center retrospective series (2013) (20)
- Failure of pallidal deep brain stimulation in DYT12-ATP1A3 dystonia. (2017) (19)
- Acute challenge with apomorphine in Huntington's disease: a double-blind study. (1995) (19)
- Gastrointestinal smooth muscles and sphincters spasms: treatment with botulinum neurotoxin. (2003) (18)
- Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment (2011) (18)
- Cortical myoclonus in childhood and juvenile onset Huntington's disease. (2012) (18)
- Botulinum toxin for the management of adult patients with upper motor neuron syndrome. (2009) (18)
- Tardive lingual dystonia treated with clozapine (1996) (18)
- Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review. (2016) (17)
- Botulinum toxin in motor disorders. (1999) (17)
- Impact of nonmotor symptoms on disability in patients with Parkinson’s disease (2011) (17)
- Clinical Reasoning: A case of COVID-19–associated pharyngeal-cervical-brachial variant of Guillain-Barré syndrome (2020) (17)
- Demographic and clinical determinants of neck pain in idiopathic cervical dystonia (2020) (17)
- Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? (2020) (17)
- A study of arm movements in Huntington's disease under visually controlled and blindfolded conditions (2003) (17)
- Retrograde fluorescent neuronal tracing combined with acetylcholinesterase histochemistry (1982) (17)
- Identification of a novel primary torsion dystonia locus (DYT13) on chromosome 1p36 in an Italian family with cranial-cervical or upper limb onset (2001) (17)
- Functional motor phenotypes: to lump or to split? (2021) (16)
- Behavioral and personality features in patients with lateralized Parkinson’s disease (2011) (16)
- Severe Barbiturate Withdrawal Syndrome in Migrainous Patients (1996) (16)
- Idiopathic Non‐task‐Specific Upper Limb Dystonia, a Neglected Form of Dystonia (2020) (16)
- [Consensus on the diagnosis of multi-system atrophy]. (1999) (16)
- Chronic administration of MPTP to monkeys: Behavioural morphological and biochemical correlates (1992) (16)
- Excessively High Magnetic Resonance Signal in Preterm Infants and Neuropsychobehavioural Follow-up at 2 Years (2005) (16)
- Copper Imbalance in Alzheimer’s Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants (2021) (15)
- Peripheral neuropathy in the course of progressive systemic sclerosis: Light and ultrastructural study (1982) (15)
- Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study. (2018) (15)
- Acute administration of individual optimal dose of physostigmine fails to improve mnesic performances in Alzheimers Presenile Dementia. (1983) (15)
- Can trazodone induce parkinsonism? (1988) (15)
- Recent developments in clinical trials of botulinum neurotoxins. (2018) (14)
- The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease (2020) (14)
- Designing Clinical Trials for Dystonia (2013) (14)
- Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists (2003) (14)
- Cholinergic-Monoaminergic Interactions in Selected Regions of the Brain: Histochemical and Pharmacologic Analyses (1981) (13)
- Phenotype variability of dystonia in monozygotic twins (2000) (13)
- Concordance between severity of disease, prevalence of nonmotor symptoms, patient-reported quality of life and disability and use of medication in Parkinson’s disease (2012) (13)
- VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's Disease (2019) (13)
- Quality and reporting of guidelines on the diagnosis and management of dystonia (2018) (13)
- Erratum to: Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association (2013) (13)
- Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases (2022) (13)
- Quantitative pharmacohistochemistry of acetylcholinesterase in neostriatum of inbred strains of mice (1986) (13)
- Onset and progression of primary torsion dystonia in sporadic and familial cases (2006) (12)
- Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials. (2015) (12)
- Classifying tremor: Language matters (2018) (11)
- Attentional Networks in Parkinson’s Disease (2013) (11)
- Primary Focal Hyperhidrosis in a New Family Not Linked to Known Loci (2012) (11)
- Shifting from constant-voltage to constant-current in Parkinson’s disease patients with chronic stimulation (2017) (11)
- Nanotechnology and vascular neurosurgery: an in vivo experimental study on microvessels repair using laser photoactivation of a nanostructured hyaluronan solder. (2012) (11)
- Choice-option evaluation is preserved in early Huntington and Parkinson’s disease (2011) (11)
- Discussion of unique properties of botulinum toxins. (2009) (11)
- Distinguishing scan without evidence of dopaminergic depletion patients with asymmetric resting tremor from Parkinson's disease: A clinical diagnosis of dystonia is required (2010) (11)
- EXTRAPYRAMIDAL SYSTEM, MOTOR GANGLIA AND MOVEMENT DISORDERS (1990) (10)
- Subthalamic involvement in monetary reward and its dysfunction in parkinsonian gamblers (2014) (10)
- Distinguishing Clinical Features of Hyperkinetic Disorders (2012) (10)
- Postural axial tremor in a patient with cerebellar atrophy (1992) (10)
- An experimental study on minimally occlusive laser-assisted vascular anastomosis in bypass surgery: the importance of temperature monitoring during laser welding procedures. (2010) (9)
- Three-dimensional rotational angiography for craniotomy planning and postintervention evaluation of intracranial aneurysms (2013) (9)
- Faculty Opinions recommendation of Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. (2009) (8)
- Clinical guidelines: No more mistaken identities for botulinum neurotoxins (2016) (8)
- The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism. (1996) (8)
- Boxer disqualified for taking selegiline (1995) (8)
- Normal cardiovascular reflex testing in patients with parkin disease (2007) (8)
- TWNK in Parkinson's Disease: A Movement Disorder and Mitochondrial Disease Center Perspective Study (2022) (8)
- Implementation of the Current Dystonia Classification from 2013 to 2018 (2019) (8)
- “Complex” dystonia is not a category in the new 2013 consensus classification (2016) (7)
- Emerging parkinsonian phenotypes. (2010) (7)
- Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experience (2020) (7)
- Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes (2016) (7)
- Trigeminal features in COVID‐19 patients with smell impairment (2021) (7)
- Advances in the genetics of primary torsion dystonia (2010) (7)
- Mechanical somatosensory stimulation decreases blood pressure in patients with Parkinson's disease. (2019) (7)
- Deep Brain Stimulation for Parkinson's Disease: Where Do We Stand? (2011) (6)
- Protective effect of external ventricular drainage on cerebral vasospasm. A retrospective study on aneurysmal SAH treated endovascularly (2014) (6)
- Transcranial cerebral herniation after chronic subdural hematoma treatment with no dura closure (2006) (6)
- Chronic administration of MPTP to marmosets. (1990) (6)
- Can falls be prevented in Parkinson’s disease? (2006) (6)
- Management of bladder, prostatic and pelvic floor disorders (2006) (6)
- Localization of MPP+ binding sites in the brain of various mammalian species (1992) (6)
- Emerging treatments in Parkinson's disease. (1997) (6)
- A genetic study of neostriatal cholinergic neurones in C57BL/6 and DBA/2 mice. (1987) (5)
- Correlation of cardiovascular autonomic function tests, magnetic resonance brain imaging and clinical features in suspect cases of multiple system atrophy. (1991) (5)
- Clinical Use of Botulinum Neurotoxin: Neuromuscular Disorders (2014) (5)
- Iconographies supplémentaires de l'article : Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation (2012) (5)
- Histochemical demonstration of heavy metals in the reptilian archicortex. (1985) (5)
- Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry (2020) (5)
- Reply from the authors [4] (2007) (5)
- Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study. (1982) (5)
- Deep brain stimulation for cervical dystonia (2014) (5)
- Bipolar swings in mood in a patient with bilateral subtbalamic deep brain stimulatlon (DBS) free of antiparkinsonian medication. (1999) (5)
- Reliability and validity of the range of motion scale (ROMS) in patients with abnormal postures. (2015) (5)
- Unique properties of botulinum toxins. (2009) (5)
- Dystonia in parkinsonian syndromes. (2003) (4)
- Pure surgical treatment of 109 aneurysms. (2005) (4)
- Review of disease-modifying drug trials in amyotrophic lateral sclerosis (2022) (4)
- A multicenter Italian randomised study on early treatment of Parkinson disease: comparison of 1-dopa, 1-deprenyl and dopaminoagonists. Study design and short term results (1992) (4)
- Loss of cholinergic neurons in the basal ganglia of aged rats (1986) (4)
- Design and Operation of the Lombardy Parkinson's Disease Network (2020) (4)
- Adult diagnosis of Cockayne syndrome (2019) (4)
- Recent developments in clinical trials of bont (2016) (4)
- Ambiguous idiom processing in Parkinson's disease patients (2014) (4)
- Dystonia Management: What to Expect From the Future? The Perspectives of Patients and Clinicians Within DystoniaNet Europe (2021) (4)
- Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. (2004) (4)
- Unsuspected, surreptitious drug‐induced parkinsonism (1992) (4)
- Cell therapy for Parkinson's disease: have the glory days gone? (2011) (4)
- Erratum to: Substantia nigra in Parkinson’s disease: a multimodal MRI comparison between early and advanced stages of the disease (2014) (4)
- The current model of basal ganglia organization: a clinician's view. (1998) (4)
- Neuroimaging in idiopathic adult-onset focal dystonia (2021) (4)
- Gabapentin improved sensory and motor symptoms in the restless legs syndrome (2003) (4)
- Apomorphine and levodopa challenge in patients with a focal midbrain lesion (1999) (4)
- Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site. (2021) (3)
- Phenotypic characterisation of DYT13 primary torsion distonia. (2004) (3)
- Multiple system atrophy [2] (1996) (3)
- Clinical genetic study of familial Parkinson's disease in Italy. (1999) (3)
- Diagnostic issues in childhood and adult dystonia. (2011) (3)
- Chapter 12 – Clinical Trials of Botulinum Toxin in Adult Spasticity (2009) (3)
- Clinical Features of Dystonia and European Guidelines for Diagnosis and Treatment (2007) (3)
- Hearing loss after cerebrospinal fluid shunt and its resolution following programmable valve adjustment (2007) (3)
- Functional gait disorders: Demographic and clinical correlations. (2021) (3)
- Erratum: Levodopa in the treatment of Parkinson's disease: Current controversies (Movement Disorders) (2004)) (2005) (3)
- Positional Brain Ischemia with MCA Occlusion Successfully Treated with Extra-Intracranial Bypass (2010) (3)
- Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long‐term clinical trials (2011) (3)
- Biochemical differences between the left and right hemispheres. Preliminary observations on choline acetyl transferase (CAT) activity. (1980) (3)
- A randomised controlled trial of a home based exercise programme to reduce the risk of falling among people with Parkinson's disease. Editorial Commentary (2007) (2)
- New delivery systems for antiparkinsonian drugs. (1999) (2)
- Impulse control behavior in GBA-mutated parkinsonian patients (2020) (2)
- Development of a patient journey map for people living with cervical dystonia (2022) (2)
- Safety recommendations for treatment with botulinum toxin during the COVID-19 pandemic prepared by the Italian botulinum toxin network in collaboration with the accademia LIMPE-DisMov, SISC, and ANIRCEF associations (2021) (2)
- Chronic Administration of 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine to Marmosets (1991) (2)
- Transient alternating hemichorea as presenting sign of progressive supranuclear palsy (1991) (2)
- Chapter 10 – Botulinum Neurotoxin in Tremors, Tics, Hemifacial Spasm, Spasmodic Dysphonia, and Stuttering (2009) (2)
- Terminology for Preparations of Botulinum Neurotoxins (2011) (2)
- Functional impairment of nigrostriatal neurons progresses following withdrawal of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (1996) (2)
- Prefrontal Cortical Stimulation in Tourette Disorder: Proof‐of‐concept Clinical and Neuroimaging Study (2018) (2)
- Guest Editors' introduction (2011) (2)
- Neurological research & training after the easing of lockdown in countries impacted by COVID-19 (2020) (2)
- “Gluing” phenotypes together (2011) (2)
- Coronary embolization from aortic valve fibroelastoma (2020) (2)
- Rivastigmine in Parkinson’s disease dementia (2008) (2)
- Neuropsychiatric Disturbances in Dystonia (2015) (1)
- Editorial: Unmet Needs in Dystonia (2017) (1)
- Clinical trials in pediatric ALS: a TRICALS feasibility study (2022) (1)
- Identification of PINK1, the first mitochondrial gene causing Parkinson's disease (2004) (1)
- Amyotrophic onset in GCH1 dopa-responsive dystonia (2019) (1)
- Diagnosis and Treatment of Primary (Idiopathic) Dystonia (2010) (1)
- Pathophysiology and molecular pathology of dystonia and tics. in: Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment (2012) (1)
- Experimental study on laser assisted vascular repair and anastomosis with ICG-infused chitosan films (2011) (1)
- Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders? (2022) (1)
- Autonomic dysfunction in Parkinson's disease associated with common glucocerebrosidase gene mutations (2016) (1)
- Corrigendum to “Early detection of wearing off in Parkinson disease: The DEEP study” [Parkinsonism Relat Disorder 20 (2014) 204–211] (2015) (1)
- Cutaneous herpes zoster and implantable pulse generator (2010) (1)
- Quantitative gait analysis in parkin disease (2013) (1)
- Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment, with Desktop Edition (2012) (1)
- A 52‐Year‐Old Man with Myoclonic Jerks (2016) (1)
- 8. Primary Dystonias (2012) (1)
- Sudden Onset, Fixed Dystonia and Acute Peripheral Trauma as Diagnostic Clues for Functional Dystonia (2021) (1)
- Management of sleep disorders in Parkinson's disease (2016) (1)
- Focal Cerebral Infarction in Newborn: Description of Three Cases (2004) (1)
- THE GENETIC BASIS OF MOVEMENT DISORDERS (1998) (1)
- Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: ITALY. (2013) (1)
- Eligibility criteria in clinical trials for cervical dystonia. (2022) (1)
- Review: several drugs are efficacious for symptomatic treatment of Parkinson disease. (2003) (1)
- Correction to: Demographic and clinical determinants of neck pain in idiopathic cervical dystonia (2020) (1)
- Parkinsonism and dysautonomia: Multiple system atrophy? (2020) (1)
- Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol (2022) (1)
- Oligophrenia with the Hallermann-Streiff syndrome (1979) (1)
- Early visual memory deficits (2012) (1)
- 5-28-10 Neurophysiological evaluation of Parkinson's disease patients with implanted electrodes in subthalamic nuclei (1997) (0)
- Target choice for surgical therapy (1997) (0)
- Toxins 2017 conference in Madrid. (2018) (0)
- Faculty Opinions recommendation of Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. (2008) (0)
- P2.062 MLPA analysis in EOP patients (2009) (0)
- P7.7 Prefrontal stimulation in Tourette syndrome (2011) (0)
- Faculty Opinions recommendation of Tremor in primary adult-onset dystonia: prevalence and associated clinical features. (2013) (0)
- Phenotypic features of severe familial generalized idiopathic torsion dystonia (ITD) (1997) (0)
- Multiple System Atrophy-Reply (1996) (0)
- Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases (2022) (0)
- P7.8 Premotor cortical stimulation in primary dystonia (2011) (0)
- Clinical characterization of Italian families affected by purely focal idiopathic torsion dystonia (1998) (0)
- Data-driven clustering of combined Functional Motor Disorders based on the Italian registry (2022) (0)
- Toxins 2017 conference in Madrid. (2018) (0)
- Clinical Uses of Botulinum Toxins: Hypersalivation (2007) (0)
- Correction to: COVID‑19‑associated Guillain‑Barré syndrome in the early pandemic experience in Lombardia (Italy) (2022) (0)
- Late perforation of the bowel in patients with a ventriculoperitoneal shunt (2006) (0)
- Faculty Opinions recommendation of Premotor signs and symptoms of multiple system atrophy. (2012) (0)
- Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (2018) (0)
- Electrophysiological findings in cerebellar anterior lobe atrophy (1990) (0)
- Multiple system atrophy: clinico- laboratory correlations (1991) (0)
- Isolated Cervical Dystonia: Diagnosis and Classification. (2023) (0)
- Multiple system atrophy - Reply (vol 53, pg 212, 1996) (1996) (0)
- Faculty of 1000 evaluation for The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. (2011) (0)
- Minimally Invasive Mitral Valve Surgery: Which Cross-clamp Should I Apply? (2019) (0)
- Reply to Dr Michaud et al. (2015) (0)
- diagnostic criteria . parkinsonism : clinical features and Multiple system atrophy presenting as and (0)
- Pre-frontal cortical stimulation in Tourette Syndrome (2010) (0)
- Imaging Acute NeurologicDisease: Hyperkinesia, dystonia, and tics (2014) (0)
- Cerebral Magnetic Resonance Imaging as Predictor of Learning Disabilities in Extremely Low Birth Weight (2004) (0)
- Editorial: Toxins 2017. (2016) (0)
- Deep Brain Stimulation in Dystonia: Disentangling Heterogeneity (2020) (0)
- GBA mutations in PD? Early visual memory deficits : A neuropsychological marker of (2012) (0)
- COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy) (2022) (0)
- Longterm results of surgical treatment of acute type A aortic dissection (2006) (0)
- P3.030 GBA mutations and Parkinson disease in Italian population (2009) (0)
- Neurology in the European Journal of Neurology (2010) (0)
- Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site, data from the Italian dystonia registry (2021) (0)
- OPINION Update on dystonia (2012) (0)
- Other primary generalized dystonias (2007) (0)
- Patient-centred management of Parkinson's disease (2020) (0)
- P6.11 Kinematic, dynamic and EMG simultaneous evaluation of patients with primary dystonia (2011) (0)
- Histological evaluation of laser-assisted carotid by-pass. Experimental study. (2005) (0)
- Initial bromocriptine did not change mortality in early, mild Parkinson disease. (2002) (0)
- The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes (2022) (0)
- Smooth muscle spasms and sphincters. (2004) (0)
- Tics and Tremors (2015) (0)
- Chronic electrical stimulation of the subtalamus as a treatment of complicate Parkinson's disease (1997) (0)
- Impulsive control behaviours in patients with GBA, PARK2 and without mutations in genes associated to Parkinson disease (2020) (0)
- Contents Vol. 223, 2011 (2012) (0)
- Compléments : Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation (2012) (0)
- 3.15.4 CLINICAL MANAGEMENT OF PAIN AND FATIGUE IN PD (2012) (0)
- Multiple system atrophy: a probability score based on clinical and laboratory data (1991) (0)
- Management algorithm for BoNT injections with electromyography and ultrasound guidance in cervical dystonia (2018) (0)
- MULTIPLE SYSTEM ATROPHY. AUTHORS' REPLY (1996) (0)
- Unmet Needs in Dystonia (2017) (0)
- Parkinson disease and the law: motor and non-motor determinants in medical courts cases (2020) (0)
- P15.5 Familial primary focal hyperhidrosis: neurophysiological assessment of cardiovascular autonomic function (2011) (0)
- PINK1 mutations cause typical late-onset Parkinson's disease as well as early-onset Parkinsonism. (2006) (0)
- ischemica mitral regurgitation:mitral valve repair with cabg vs cabg alone (2005) (0)
- Comprar Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment, with Desktop Edition | Joseph Jankovic, MD | 9781444333527 | Wiley (2012) (0)
- The Ewing Score in the Diagnosis and Follow-up of Autonomic Failure in Patients with Multiple System Atrophy (1999) (0)
- Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis (2023) (0)
- Action-induced upper limb dystonia following a demyelinating lesion inthe cervical spinal cord (1997) (0)
- Uncommon Causes of Movement Disorders: Restless legs syndrome and sleep-related disorders (2011) (0)
- Zona incerta stimulation in a patient with post traumatic complex tremor: Instrumented evaluation (2012) (0)
- Motor and non-motor features of Parkinson's disease patients ten years after subthalamic implants (2011) (0)
- 3. Focal dystonias: Rating scales (2015) (0)
- Reply: Dystonia after severe head injuries (2014) (0)
- Botulinum neurotoxin revisited – An individualised, patient-centric approach for the treatment of dystonia and spasticity (2015) (0)
- Improvement in Cervical Dystonia – Outcomes of a Prospective, Multicenter, International Registry of Deep Brain Stimulation (DBS) (P11-11.002) (2023) (0)
- Pharmacogenetics of psychotropic drugs (2003) (0)
- Designing Clinical Trials for Dystonia (2013) (0)
- P7.20 Bilateral, pallidal deep-brain stimulation in primary and non-primary dystonia: a prospective long-term follow-up study (2011) (0)
- G07 Differences between Huntington's disease and spinocerebellar ataxia types 1 and 2 on cognitive and behavioural profile (2010) (0)
- Hyperkinetic Disorders Hyperkinetic Movement Disorders (2012) (0)
- Faculty Opinions recommendation of Altered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndrome. (2010) (0)
- Special Issue: Toxins 2008: Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins Foreword (2009) (0)
- Neuropsychological assessment in patients with Parkinson's disease associated with PARK2 gene mutations: A case-control study (2016) (0)
- The clinical diagnosis of multiple system atrophy based on a probability score (1993) (0)
- PARK6 Linked Parkinson's Disease Is Caused by Mutations in a Mitochondrial Protein Kinase (2004) (0)
- BREAKFAST SEMINARS, THURSDAY, JUNE 20, 1996 (1996) (0)
- Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease (2022) (0)
- Drug Profi le Rivastigmine in Parkinson ’ s disease dementia (2008) (0)
- Neuropeptides in dopamine-containing regions of the brain (1984) (0)
- 1.134 Pain and Parkinson's disease: A case-control Italian multicenter study (2007) (0)
- Cueing brain rhythms in Parkinson’s disease (2021) (0)
This paper list is powered by the following services:
Other Resources About Alberto Albanese
What Schools Are Affiliated With Alberto Albanese?
Alberto Albanese is affiliated with the following schools:
